SRC-Homology 2 Domain-Containing Phosphatase 2 (SHP2) in Resected Lung Adenocarcinoma (LUAD)

被引：0
|
作者：
Ito, M. [1 ]
Codony-Servat, J. [2 ]
Gimenez-Capitan, A. [2 ]
Serra-Mitjans, M. [3 ]
Perez-Ochoa, F. [4 ]
Llige, D. [5 ]
Chaib, I. [5 ]
Rami-Porta, R. [6 ]
Obiols, C. [3 ]
Call, S. [3 ]
Belda-Sanchis, J. [3 ]
Tarroch-Sarasa, X. [4 ]
Karachaliou, N. [2 ]
Molina-Vila, M. A. [2 ]
Okada, M. [1 ]
Rosell, R. [5 ]
机构：
[1] Hiroshima Univ, Dept Surg Oncol, Hiroshima, Japan
[2] Pangaea Oncol, Lab Mol Biol, Barcelona, Spain
[3] Hosp Mutua Terrassa, Thorac Surg, Barcelona, Spain
[4] Hosp Mutua Terrassa, Pathol, Barcelona, Spain
[5] Inst Hlth Sci Res Germans Trias & Pujol Igtp, Lab Canc Biol, Barcelona, Spain
[6] Hosp Univ Mutua Terrassa, Thorac Surg, Terrassa, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
SHP2; resected lung adenocarcinoma; EGFR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP12.03
引用
收藏
页码：S217 / S218
页数：2
相关论文
共 50 条
  • [31] Investigating the reason for loss-of-function of Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) caused by Y279C mutation through molecular dynamics simulation
    Liu, Wen-Shan
    Wang, Rui-Rui
    Li, Wei-Ya
    Rong, Mei
    Liu, Chi-Lu
    Ma, Ying
    Wang, Run-Ling
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (09): : 2509 - 2520
  • [32] Src Homology 2 Domain-containing Phosphatase 2 (Shp2) Is a Component of the A-kinase-anchoring Protein (AKAP)-Lbc Complex and Is Inhibited by Protein Kinase A (PKA) under Pathological Hypertrophic Conditions in the Heart
    Burmeister, Brian T.
    Taglieri, Domenico M.
    Wang, Li
    Carnegie, Graeme K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (48) : 40535 - 40546
  • [33] Expressions of Src homology 2 domain-containing phosphatase and its clinical significance in laryngeal carcinoma
    Dong, L. B.
    Li, G. Q.
    Tian, Z. H.
    Wang, Z. M.
    Xu, K.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (04) : 4207 - 4212
  • [34] Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors
    Satheeshkumar, Rajendran
    Zhu, Rui
    Feng, Bo
    Huang, Chao
    Gao, Ya
    Gao, Li-Xin
    Shen, Chao
    Hou, Ting-Jun
    Xu, Lei
    Li, Jia
    Zhu, Yun-Long
    Zhou, Yu-Bo
    Wang, Wen-Long
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (11)
  • [35] Regulation of peripheral and central immunity: Understanding the role of Src homology 2 domain-containing tyrosine phosphatases, SHP-1 & SHP-2
    Garg, Manika
    Wahid, Mohd
    Khan, Farah
    IMMUNOBIOLOGY, 2020, 225 (01)
  • [36] Src homology-2 (sh2) domain-containing phosphatase 2 (shp2) recruitment to the growth hormone receptor mediates short term attenuation of liver growth hormone signaling by tumor necrosis factor alpha
    He, JM
    Bonkowski, E
    Denson, L
    GASTROENTEROLOGY, 2005, 128 (04) : A487 - A487
  • [37] Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro
    Xie, Hongjun
    Huang, Shengyun
    Li, Wengang
    Zhao, Hongbo
    Zhang, Tianqi
    Zhang, Dongsheng
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2014, 117 (02): : 234 - 242
  • [38] Association of the Src homology 2 domain-containing inositol 5′ phosphatase (SHIP) to releasability in human basophils
    MacDonald, SM
    Vonakis, BM
    MOLECULAR IMMUNOLOGY, 2002, 38 (16-18) : 1323 - 1327
  • [39] Enzymatic activity of the Src homology 2 domain-containing inositol phosphatase is regulated by a plasma membrane location
    Phee, H
    Jacob, A
    Coggeshall, KM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (25) : 19090 - 19097
  • [40] Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)
    Day, James E. H.
    Berdini, Valerio
    Castro, Joan
    Chessari, Gianni
    Davies, Thomas G.
    Day, Philip J.
    St. Denis, Jeffrey D.
    Fujiwara, Hideto
    Fukaya, Satoshi
    Hamlett, Christopher C. F.
    Hearn, Keisha
    Hiscock, Steven D.
    Holvey, Rhian S.
    Ito, Satoru
    Kandola, Navrohit
    Kodama, Yasuo
    Liebeschuetz, John W.
    Martins, Vanessa
    Matsuo, Kenichi
    Mortenson, Paul N.
    Muench, Sandra
    Nakatsuru, Yoko
    Ochiiwa, Hiroaki
    Palmer, Nicholas
    Peakman, Torren
    Price, Amanda
    Reader, Michael
    Rees, David C.
    Rich, Sharna J.
    Shah, Alpesh
    Shibata, Yoshihiro
    Smyth, Tomoko
    Twigg, David G.
    Wallis, Nicola G.
    Williams, Glyn
    Wilsher, Nicola E.
    Woodhead, Andrew
    Shimamura, Tadashi
    Johnson, Christopher N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (06) : 4655 - 4675
12345